Glenmark Generics Inc. (GGI), USA is the North American division of Glenmark Generics Ltd. (GGL) dedicated to the manufacture, marketing and distribution of generic pharmaceutical products. Read more.

Glenmark Generics (Europe) Limited (GGEL) is the European subsidiary of Glenmark Generics Ltd., engaged in marketing, licensing and distribution of generic products throughout Europe.The generic formulations and API business in Europe has a robust product portfolio developed by a Europe-dedicated R&D team and has excellent supply chain resources. Read more.

Glenmark Generics Argentina is the hub for generic research, manufacturing and distribution of oncology products for the whole world. The company’s continuous growth since then now spans 23 countries. Read More.

Glenmark API is the Active Pharmaceutical Ingredient manufacturing arm of Glenmark Generics. With a presence in over 80 countries Glenmark's API business is among the top 10 in the Indian Generic Pharmaceutical Market. Read more.

January 22, 2010 : Glenmark Generics Ltd granted tentative approval by US-FDA for Trandolapril and Verapamil Hydrochloride extended-release tablets • Glenmark believes that as of date it has sole first-to-file status on this product Read More

December 24, 2009 : Glenmark Generics Ltd receives Tentative Approval from USFDA for Pramipexole Dihydrochloride tablets and Atomoxetine Hydrochloride capsules Read More